Delivery Order SPE2DB24D1104-SPE2DB25FYFR4
- Not listed
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens on July 28, 2025, with an ultimate completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,929.20 to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 9, 2025, with completion targeted for September 30, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, with an ultimate completion date of September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order transaction under AmerisourceBergen's larger federal contract portfolio with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 MG pens, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader federal contracting relationship with the agency. This...
- The Defense Logistics Agency awarded a $1,929.20 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens, with an ultimate completion date of August 22, 2025. This contract was competitively awarded without set-aside designation under firm fixed price terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,858.40 to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 8, 2025, with completion scheduled for September 29, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a $7,716.80 delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens on September 2, 2025, with completion targeted for September 23, 2025. This firm fixed-price contract, which was competitively awarded without set-aside restrictions, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The pharmaceutical distributor,...
- The Defense Logistics Agency issued a delivery order for NEMLUVIO 30 mg pens valued at $3,858.40 to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The award, made on August 25, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The contract carries no set-aside designation, indicating it was competitively awarded through open procurement. Performance will take place at...
- The Defense Logistics Agency awarded a $3,858.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Nemluvio 30 mg pens, with an ultimate completion date of September 18, 2025. This is an unset-aside, competitively awarded contract utilizing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,858.40 delivery order to AmerisourceBergen Drug Corp for Nemluvio 30 mg pens, with a completion date of September 18, 2025. This is a firm fixed-price, non-set-aside contract utilizing competitive procurement procedures. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a continuation of the company's extensive federal pharmaceutical supply...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFR4Delivery Order
The Defense Logistics Agency awarded a $3,858.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for NEMLUVIO 30 mg pens with an ultimate completion date of October 1, 2025. This competitive award, issued on September 10, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as the contractor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As a prime contractor on the DLA Troop Support Medical contract, the company supplies a comprehensive range of pharmaceutical products and medical devices to support Defense Health Agency operations and other government healthcare systems. This specific delivery order for NEMLUVIO (an injectable diabetes and weight loss medication) reflects the contractor's role in providing specialized pharmaceutical commodities across multiple therapeutic domains to support federal medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/10/25 |